In biology, an is a short peptide (usually 15–70 amino acids) located at the N-terminus of a protein. It acts as a "molecular ZIP code," directing the protein from the cytoplasm to its final home within the mitochondria.
In the world of high-stakes biological research, the term is a shorthand typically used by researchers to refer to two distinct but related concepts: Mitochondrial Targeting Sequences (MTS) and the prestigious journal Nature Communications (NatComm) .
Publishing an MTS-related discovery in Nature Communications is a major milestone. With a 2024 and an acceptance rate of only ~8% , the journal is highly selective, favoring research with "genuine cross-field appeal". mts-natcomm
: MTSs are typically amphipathic helices , meaning one side is hydrophobic while the other is positively charged.
: Data suggests the median desk decision (rejecting or moving to review) takes roughly 8 days , while the total time from submission to acceptance averages 4.3 months . 3. Why "mts-natcomm" Matters for Your Career In biology, an is a short peptide (usually
: Nature Communications frequently publishes cutting-edge research on MTS design. For instance, recent studies have used Variational Autoencoders (VAEs) to design "new-to-nature" MTSs, achieving up to 100% success in vivo.
Whether you are navigating the Nature Communications Manuscript Tracking System (MTS) or researching the latest breakthroughs in protein localization, understanding these terms is vital for any modern life scientist. : Data suggests the median desk decision (rejecting
: Errors in MTS recognition are linked to severe mitochondrial diseases. Research published in Nature Communications has identified the TIM23 machinery (which recognizes MTSs) as a potential therapeutic target for ATP synthase disorders.
1. The Scientific Core: Mitochondrial Targeting Sequences (MTS)
